MedPath
NMPA Approval

Dobutamine Hydrochloride Injection

国药准字H20243911

June 4, 2024

Drug Information

盐酸多巴酚丁胺注射液

注射剂

5ml∶100mg(按C₁₈H₂₃NO₃计)

化学药品

June 4, 2024

Company Information

Applicant Company

北京市大兴区天华大街5号院3号楼13层1311

Manufacturing Company

北京市大兴区中关村科技园区大兴生物医药产业基地天贵大街16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.